Tue July 21 – 10 Stories of The Day!

1 – Encouraging results from phase 1/2 COVID-19 vaccine trials – The Lancet

Podcast: The Lancet Editor-in-Chief Richard Horton explains the current status of the Oxford and China COVID-19 vaccines

Commentaries: Promising early findings for 2 more COVID-19 vaccines – CIDRAP AND Expert reaction to two vaccine candidate studies: a phase 1/2 trial of the University of Oxford’s ChAdOx1 vaccine candidate; and a phase 2 trial of China’s Ad5-vectored COVID-19 vaccine candidate – Science Media Centre

2 – Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial – The Lancet

Commentaries: New study reveals Oxford coronavirus vaccine produces strong immune response – University of Oxford AND Oxford’s Covid-19 vaccine appears safe and induces immune response, early results suggest, but more research is needed – CNN AND Early Oxford-AstraZeneca Coronavirus Vaccine Data ‘Encouraging,’ Scientists Say – NPR

3 – Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial – The Lancet

Commentaries: China’s Ad5 vectored COVID-19 vaccine safe and induces immune response – News Medical AND CanSino COVID-19 vaccine generates immune response in 90% of patients – UPI

4 – Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients

Commentaries: New Treatment for Covid-19 Shows Promise, but Scientists Urge Caution – The New York Times AND Expert reaction to announcement by Synairgen that their drug SNG001 has had positive results in initial trials on COVID-19 patients – Science Media Centre AND Trial of Covid-19 drug given via inhaler ‘very promising’, say scientists – The Guardian

5 – Symptom clusters in Covid19: A potential clinical prediction tool from the COVID Symptom study app – medRxiv

Commentaries: Covid-19: Study reveals six clusters of symptoms that could be used as a clinical prediction tool – The BMJ AND Six distinct ‘types’ of COVID-19 identified – King’s College London AND Coronavirus symptoms fall into six different groupings, study finds – The Guardian

6 – Survivorship after COVID-19 ICU stay – Nature Reviews

7 – Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany – JAMA

8 – Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System – JAMA

9 – The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study – The Lancet Oncology

10 –COVID-19 Updates / 21 July 2020 Edition

21 July 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)